CClinicalTrials.gg
Status unknownNCT03938428PEPPRUpdated Aug 12, 2019

The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews

An observational study in Pharmaceutical Preparations, Accidental Fall and Allied Health Personnel, sponsored by Yorkshire Ambulance Service NHS Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2019-08-12.

Sponsored by Yorkshire Ambulance Service NHS Trust · Observational

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
132
Ages
18 Years to 110 Years
Sex
All
01

Study summary

This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.

Read the detailed description

Falls in people aged 65 years and over are a common reason for calling the emergency ambulance service. Falls can be serious, with about 1 in 20 people having to be taken to hospital because they have been injured. Thankfully, in more than 4 out of 10 cases, people are not seriously injured and can be left at home. However, it is important that the reason for the fall is found and future falls are prevented where possible.

Yorkshire Ambulance Service can already make a referral to another local service to get specialist practical help for falls prevention when people are left at home after a fall. Research has shown that the safe use of medicines can prevent future falls, but that did not form. Now a new service has been set up for Yorkshire Ambulance Service to refer patients to the Leeds GP Confederation. A pharmacist working in the patients GP surgery will undertake a review of the patient's use of their medicines.

We would like to find out about how patients feel about using their medicines before and after the medicines review by a pharmacist. We would also like to know how they feel about the medicines review itself, to help decide whether this scheme should continue or be expanded to other areas. To do this, we are going to send a questionnaire to patients who receive a medicines review. The questionnaire will be sent by post, take about 10 minutes to fill out and include a stamped addressed envelope so people who take part will not have to pay for postage.

02

Conditions studied

  • Pharmaceutical Preparations
  • Accidental Fall
  • Allied Health Personnel
03

In context

Lead sponsor

Yorkshire Ambulance Service NHS Trust is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will be conducted from a single site (Yorkshire Ambulance Service NHS Trust). YAS staff make around 70-100 falls referral pathways a month in the Leeds area, and after exclusions relating to the PREFACS projects, it is anticipated that around 55 patients per month will be eligible to receive a pharmacist-led clinical medication review and will therefore be eligible for this study, up to a maximum of 550 patients.

Inclusion criteria

  • Received a pharmacist-led clinical medication review following a falls referral made by a paramedic from Yorkshire Ambulance
  • Registered with a GP in the Leeds area
  • Has capacity to consent to take part in the study

Exclusion criteria

Exclusion Criteria:

  • Did not receive a pharmacist-led clinical medication review after a Yorkshire Ambulance Service paramedic made a falls referral
  • Not registered with a GP in the Leeds area
  • Does not have capacity to consent to take part in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
132 participants (estimated)
Patient registry
No

Interventions

  • OtherSurvey

    Patients who are eligible for this study will have been previously identified as part of the PREFACES project. The pharmacist who has conducted the clinical medication review will obtain verbal permission from the patient to be contacted by the research study team. This will be documented on the referral outcome document that is returned to the YAS clinical team. A member of YAS clinical staff from the PREFACES project will forward the name and residential address of patients who have agreed to be contacted to the research paramedic for this study. A covering letter, participant information sheet, questionnaire and consent form, will be posted to potential participants. A stamped addressed envelope will be included to enable return of the completed booklet at no costs to participants.

06

What researchers measure

Primary outcomes

  1. Proportion of patients who express a change in emotion relating to how they feel about their medicines, following a pharmacist-led clinical medication review.

    Time frame: 1 month

Secondary outcomes

  1. Patient expressed emotion

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Yorkshire Ambulance Service NHS Trust
    Wakefield, West Yorkshire WF2 0XQ, United Kingdom
    • Jane Shewan · Contact · yas.ressearch@nhs.net · +441924584224
    • Rebecca McLaren · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03938428
Lead sponsor
Yorkshire Ambulance Service NHS Trust
Collaborators
NIHR Yorkshire and Humber Patient Safety Translational Research Centre
Responsible party
Sponsor
First posted
May 6, 2019
Start date
Jul 24, 2019
Primary completion
Jun 30, 2020 (estimated)
Completion
Jun 30, 2020 (estimated)
Last update
Aug 12, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion